NL7209617A - - Google Patents

Info

Publication number
NL7209617A
NL7209617A NL7209617A NL7209617A NL7209617A NL 7209617 A NL7209617 A NL 7209617A NL 7209617 A NL7209617 A NL 7209617A NL 7209617 A NL7209617 A NL 7209617A NL 7209617 A NL7209617 A NL 7209617A
Authority
NL
Netherlands
Application number
NL7209617A
Other versions
NL160271B (nl
NL160271C (nl
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL7209617A publication Critical patent/NL7209617A/xx
Publication of NL160271B publication Critical patent/NL160271B/xx
Application granted granted Critical
Publication of NL160271C publication Critical patent/NL160271C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7209617.A 1971-07-13 1972-07-12 Werkwijze voor het bereiden van een geneesmiddel met anti- bacteriele werking; werkwijze voor het bereiden van een kanamycineverbinding. NL160271C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16231571A 1971-07-13 1971-07-13
US22137872A 1972-01-27 1972-01-27

Publications (3)

Publication Number Publication Date
NL7209617A true NL7209617A (fr) 1973-01-16
NL160271B NL160271B (nl) 1979-05-15
NL160271C NL160271C (nl) 1979-10-15

Family

ID=26858650

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7209617.A NL160271C (nl) 1971-07-13 1972-07-12 Werkwijze voor het bereiden van een geneesmiddel met anti- bacteriele werking; werkwijze voor het bereiden van een kanamycineverbinding.

Country Status (24)

Country Link
JP (1) JPS5239024B2 (fr)
AR (1) AR201265A1 (fr)
AU (1) AU462657B2 (fr)
BE (1) BE786201A (fr)
CA (1) CA966831A (fr)
CH (1) CH577502A5 (fr)
CY (1) CY953A (fr)
DD (1) DD98927A5 (fr)
DK (1) DK136251B (fr)
EG (1) EG10889A (fr)
ES (1) ES404747A1 (fr)
FI (1) FI56388C (fr)
FR (1) FR2145649B1 (fr)
GB (1) GB1401221A (fr)
HK (1) HK33678A (fr)
IE (1) IE36539B1 (fr)
IL (1) IL39872A (fr)
KE (1) KE2850A (fr)
MY (1) MY7800312A (fr)
NL (1) NL160271C (fr)
PH (2) PH9589A (fr)
SE (1) SE392470B (fr)
SG (1) SG20778G (fr)
YU (1) YU36533B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154536A (en) * 1974-11-06 1976-05-13 Banyu Pharma Co Ltd 6**nn * benjiruokishikaruboniru * kanamaishinjudotaino seiho
FR2318648A1 (fr) * 1975-07-23 1977-02-18 Roussel Uclaf Nouveau derive de la desoxystreptamine et des sels, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DK136251B (da) 1977-09-12
BE786201A (fr) 1973-01-12
JPS5239024B2 (fr) 1977-10-03
YU181872A (en) 1982-02-25
YU36533B (en) 1984-02-29
PH9589A (en) 1976-01-19
DE2234315B2 (de) 1977-03-17
GB1401221A (en) 1975-07-16
PH11440A (en) 1978-02-01
FR2145649A1 (fr) 1973-02-23
DE2234315A1 (de) 1973-02-08
ES404747A1 (es) 1976-04-16
AR201265A1 (es) 1975-02-28
CY953A (en) 1978-12-22
SG20778G (en) 1987-04-03
CH577502A5 (fr) 1976-07-15
AU4434372A (en) 1974-01-10
EG10889A (en) 1976-10-31
IE36539L (en) 1973-01-13
NL160271B (nl) 1979-05-15
FI56388B (fi) 1979-09-28
IL39872A (en) 1974-10-22
JPS4834856A (fr) 1973-05-22
MY7800312A (en) 1978-12-31
AU462657B2 (en) 1975-07-03
KE2850A (en) 1978-08-04
DD98927A5 (fr) 1973-07-12
NL160271C (nl) 1979-10-15
DK136251C (fr) 1978-02-13
FI56388C (fi) 1980-01-10
FR2145649B1 (fr) 1976-04-16
SE392470B (sv) 1977-03-28
IL39872A0 (en) 1972-09-28
CA966831A (en) 1975-04-29
HK33678A (en) 1978-07-07
IE36539B1 (en) 1976-11-24

Similar Documents

Publication Publication Date Title
ATA136472A (fr)
AU2658571A (fr)
AU2691671A (fr)
AU2485671A (fr)
AU3005371A (fr)
AU2952271A (fr)
AU2941471A (fr)
AU2894671A (fr)
AU2742671A (fr)
AU2684071A (fr)
AU2564071A (fr)
AU2473671A (fr)
AU2399971A (fr)
AU3025871A (fr)
AU2486471A (fr)
AU3038671A (fr)
AU2503871A (fr)
AU2456871A (fr)
AU2577671A (fr)
AU2588771A (fr)
AU2654071A (fr)
AU2455871A (fr)
AU2669471A (fr)
AU2415871A (fr)
AU2684171A (fr)

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: BRISTOL MYERS

V4 Discontinued because of reaching the maximum lifetime of a patent